跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
盐酸非索非那定片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Fexofenadine Hydrochloride Tablets
Approved
化学药品
Fexofenadine Hydrochloride Tablets
OPELLA HEALTHCARE FRANCE SAS
🇨🇳 National Medical Products Administration
Approval Date
Dec 4, 2025
Approval ID
887jH8PIGIm
Company
OPELLA HEALTHCARE FRANCE SAS
Type
化学药品
Approval Details
Approval Id
887jH8PIGIm
Approval Number
国药准字HJ20210011
Generic Name
盐酸非索非那定片
Generic Name En
Fexofenadine Hydrochloride Tablets
Drug Type
化学药品
Dosage Form
片剂
Strength
120mg
Reg Date
2025-12-04
Expired Date
2030-12-03
Company Name
OPELLA HEALTHCARE FRANCE SAS
Production Company Name
SANOFI WINTHROP INDUSTRIE
Company Detail Path
/organization/opella-healthcare-france-sas
Production Company Detail Path
/organization/sanofi-winthrop-industrie
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 4, 2025
Approval ID
887jH8PIGIm
Type
化学药品
Back to NMPA Approvals